Showing results (131-140 of 141) with videos related to
Sort By:
Pageof 15
Critical Care Medicine|March 24, 2017
Race, Ethnicity, Health Insurance, and Mortality in Older Survivors of Critical IllnessMatthew R Baldwin, Jessica L Sell, Nina Heyden, et al.Annals of Surgery|July 19, 2016
The Cost of Postoperative Pancreatic Fistula Versus the Cost of Pasireotide: Results from a Prospective Randomized TrialLinda W Ma, Ismael Dominguez-Rosado, Renee L Gennarelli, et al.Journal of Oncology Practice|February 13, 2018
Practice-Changing Strategies to Deliver Affordable, High-Quality Cancer Care: Summary of an Institute of Medicine WorkshopErin P Balogh, Peter B Bach, Peter D Eisenberg, et al.Journal of the National Comprehensive Cancer Network : JNCCN|April 23, 2008
NCCN Task Force Report: Oral chemotherapySaul N Weingart, Elizabeth Brown, Peter B Bach, et al.JAMA Network Open|March 22, 2022
Validation of a Population-Based Data Source to Examine National Cancer Clinical Trial ParticipationAngela K Green, Sara M Tabatabai, Xing Bai, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2024
Quality of Treatment Selection for Medicare Beneficiaries With CancerAaron P Mitchell, Sonia Persaud, Akriti Mishra Meza, et al.Gynecologic Oncology|August 21, 2020
Impact of provider volume on front-line chemotherapy guideline compliance and overall survival in elderly patients with advanced ovarian cancerEmeline M Aviki, Jessica A Lavery, Kara Long Roche, et al.JAMA|May 22, 2012
Benefits and harms of CT screening for lung cancer: a systematic reviewPeter B Bach, Joshua N Mirkin, Thomas K Oliver, et al.Chest|April 28, 2023
Cell-Free DNA Fragmentomes in the Diagnostic Evaluation of Patients With Symptoms Suggestive of Lung CancerAlessandro I C Leal, Dimitrios Mathios, Debbie Jakubowski, et al.Nature Communications|October 21, 2024
Cancer treatment monitoring using cell-free DNA fragmentomesIris van 't Erve, Bahar Alipanahi, Keith Lumbard, et al.Pageof 15